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Microcephaly is a clinical characteristic for human nijmegen breakage syndrome (NBS, mutated in NBS1 gene), 
a chromosomal instability syndrome. However, the underlying molecular pathogenesis remains elusive. In the pres-
ent study, we demonstrate that neuronal disruption of NBS (Nbn in mice) causes microcephaly characterized by the 
reduction of cerebral cortex and corpus callosum, recapitulating neuronal anomalies in human NBS. Nbs1-deficient 
neocortex shows accumulative endogenous DNA damage and defective activation of Ataxia telangiectasia and Rad3-
related (ATR)-Chk1 pathway upon DNA damage. Notably, in contrast to massive apoptotic cell death in Nbs1-
deficient cerebella, activation of p53 leads to a defective neuroprogenitor proliferation in neocortex, likely via specific 
persistent induction of hematopoietic zinc finger (Hzf) that preferentially promotes p53-mediated cell cycle arrest 
whilst inhibiting apoptosis. Moreover, Trp53 mutations substantially rescue the microcephaly in Nbs1-deficient mice. 
Thus, the present results reveal the first clue that developing neurons at different regions of brain selectively respond 
to endogenous DNA damage, and underscore an important role for Nbs1 in neurogenesis. 
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Introduction
Nijmegen breakage syndrome (NBS), caused by 
hypomorphic mutation in NBS1 [1], is a chromosomal 
instability syndrome, characterized by chromosomal 
instability, immunodeficiency, radiosensitivity, cancer 
predisposition and microcephaly. The Nbs1/Nibrin/p95 
protein is a component of the Mre11/Rad50/Nbs1 (MRN) 
complex that acts as a DNA double-strand break (DSB) 
sensor and functions in cell cycle checkpoint in response 
to DNA damage and DNA repair together with Ataxia 
telangiectasia mutated (ATM), Ataxia telangiectasia and 
Rad3-related (ATR), mediator of DNA damage check-
point protein 1 (MDC1) and H2AX [2]. Following DSBs 
in DNA, Nbs1 interacts with phosphorylated H2AX 
(γH2AX) and is responsible for the nuclear translocation 
of the Mre11/Rad50 repair complex to the sites of DNA 
damage to sense DNA strand breaks and activate ATM 
[3-5]. In addition, Nbs1 is phosphorylated by ATM, ac-
tivating downstream molecules including p53, BRCA1 
and Chk2 to control cell cycle progression [6, 7]. More-
over, it has also been demonstrated that the MRN com-
plex plays a role in single-strand break (SSB) -mediated 
ATR activation and subsequent phosphorylation of Chk1 
[8, 9]. Thus, Nbs1 or MRN also participates in mediating 
activation of ATM and ATR directly or indirectly [2, 10, 
11]. 
Genetic defects in DNA damage response (DDR) lead 
to human microcephaly syndromes, such as Nijmegen 
breakage syndrome, ATR Seckel syndrome (mutated in 
ATR [12]), and primary microcephaly (MCPH) caused by 
mutations in MCPH1 [13]. These syndromes share over-
lapping neuronal defects, indicating that microcephaly 
may be caused by alterations of neuronal progenitors in 
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response to DNA damage. 
To study the molecular pathogenesis of microcephaly 
induced by DDR defects in humans, attempts have been 
made using mouse models with disruption of NBS1 
(known as Nbn in mice) and ATR. Due to their essential 
nature in cellular function, null mutation of Nbn and ATR 
in mice lead to embryonic lethality [14, 15]. Although 
mice with hypomorphic mutations of Nbn are viable, 
they do not show obvious brain phenotypes seen in hu-
man NBS [16]. When we specifically deleted Nbn in 
mouse central nervous system (CNS) using Cre-loxP, 
these mice (Nbn
CNS-del mice) exhibited growth retardation 
and early onset of cataracts [17]. The most striking phe-
notype of these mice is an early postnatal ataxia caused 
by the agenesis of the cerebellum with decreased prolif-
eration in neuronal progenitors, and massive cell death 
in cerebellar neuronal cells [18]. In addition, Nbn
CNS-del 
mice displayed microcephaly and severely affected white 
matter integrity, retina and astrocyte functionality [19-
21]. However, the nature of cerebral reduction and the 
underlying molecular mechanism in Nbn
CNS-del mice have 
not been investigated.
Results
Neuronal disruption of Nbs1 leads to microcephaly
Macroscopically, the size and shape of the cerebrum 
was greatly reduced in the Nbn
CNS-del mice compared to its 
counterpart starting from postnatal day 7 (P7), becoming 
more evident at P14 and P21. The maximum width of 
hemisphere in 2-month-old Nbn
CNS-del and Nbn
CNS-ctr mice 
is around 4.3 ± 2 mm and 5.2 ± 2.3 mm, respectively 
(averaged from more than 20 mice of each group, P < 0.01 
(t-test), Figure 1A). To study the effect of neuronal dele-
tion of Nbn in cerebrum, we performed histological anal-
ysis on the Nbn
CNS-del brain between P7 and P21 and re-
vealed a general (~20%) reduction in thickness of the ce-
rebral cortex compared to their littermate controls (Figure 
1B). To examine the distinct morphological identities of 
cerebral cortex in details, we performed immunostaining 
with a neuronal-specific marker, neuronal nuclei (NeuN; 
Figure 1C). The cortex of the control
 mice is character-
ized by six laminas, which could be distinguished by 
packing density and neural morphology (Figure 1C). 
This laminar cortical structure was altered in Nbn
CNS-
del mice (Figure 1C). Although the layer I that contains 
Cajal-Retzius cells was similar to that in the Nbn
CNS-ctr 
cortex, the thickness of layer II/III that contains small 
pyramidal cells was reduced with less neuron cellularity 
(~76% of that in the Nbn
CNS-ctr cortex, Figure 1C and 1D). 
In addition, layers IV and V, where granule cells (GC) 
and large pyramidal cells localize, respectively, were 
less recognizable and their thickness and the cellularity 
was also decreased (~78% of that in the Nbn
CNS-ctr cortex, 
Figure 1C and 1D). However, the layer VI contained the 
similar number of polymorphic cells compared to that in 
Nbn
CNS-ctr cerebral cortex (Figure 1C and 1D). 
Similar to NBS patients, the thickness of the corpus 
callosum (CC) was reduced in Nbn
CNS-del brain (Figure 
1B, 1E and 1F). As CC is composed by tightly packed 
neural axon wrapped with myelin sheath of glial cells, 
we further examined myelin basic protein (MBP) and 
found that the density and thickness of MBP-stained neu-
ral fibers were markedly decreased (Figure 1E). There 
was a dramatic reduction of the number of medial habe-
nular neurons (Mhb) (Figure 1B), and mild alterations of 
the fasciole cinereum (fc) in Nbn
CNS-del mice (Figure 1B). 
The size of thalamic and hypothalamic region in Nbn
CNS-
del mice was also proportionally reduced compared to that 
in control brains (Figure 1B). Neurons in the CA1, CA3 
field and dentate gyrus (DG) of Nbn
CNS-del hippocampus 
were less densely packed from P7 to P21 (Figure 1E). In 
addition, Nbn
CNS-del mice displayed an increased number 
of neurons in the polymorph layer DG (PoDG, Figure 
1E). The microcephaly has been observed in Nbn
CNS-del 
mice of 129/SV × C57/BL6 mixed background origi-
nated from two independent ES clones.
Nbs1 deficiency causes severe disruption of olfactory 
bulb morphogenesis
Strikingly, Nbn
CNS-del mice displayed a severely al-
tered olfactory bulb (OB). At low magnification, NeuN 
immunostaining showed that the morphology of the 
Nbn
CNS-del OB differed from that of the Nbn
CNS-ctr mice 
(Supplementary information, Figure S1A). For instance, 
in the Nbn
CNS-ctr OB, each cell population was laminated 
at the defined structure, whereas Nbn
CNS-del OB displayed 
a reduced cellularity and less defined laminar structure 
(Supplementary information, Figure S1A, left panel). 
Further examination of the OB structure under high 
magnification revealed three major differences between 
Nbn
CNS-ctr and Nbn
CNS-del mice. First, although olfactory 
nerve layer (ONL) and glomerular layer (GL), where the 
dendrites of second-order neurons form spheroidal struc-
ture, glomeruli, were present in Nbn
CNS-del mice, the num-
ber of the periglomerular neurons was reduced (arrows, 
Supplementary information, Figure S1A). Second, the 
superficial external plexiform layer (EPL) and the lami-
nar structure of the mitral cell layer (ML) were less de-
fined in the Nbn
CNS-del mice (Supplementary information, 
Figure S1A). Third, a significant decrease in the number 
of GCs was observed in all Nbn
CNS-del OBs analyzed from 
P1 to P21 (Supplementary information, Figure S1A and 
data not shown). www.cell-research.com | Cell Research
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Figure 1 Nbs1 deficiency leads to microcephaly. (A) Macroscopic view of reduced cerebral size in Nbn
CNS-del brain, n = 20, 
P < 0.01 (t test). (B) NeuN staining of coronal section of the cerebrum at postnatal day 21 (P21), original magnification ×1. 
Cx, cerebral cortex; CC, corpus callosum; H, hippocampus; fc, fasciole cinerum; Mhb, medial habenular neurons; T, thalamic 
region; HT, hypothalamic region. (C) Representative laminar cortical structure in control and Nbn
CNS-del mice. (D) Histogram 
showing the percentage of neurons in each layer of Nbn
CNS-del cerebral cortical sections compared to control mice. At least 10 
mice of each genotype were analyzed, *P < 0.01 (t test). (E) Representative P7 hippocampus with NeuN staining (left). DG, 
dentate gyrus; CA1/CA3, field CA1/CA3 of hippocampus; PoDG, polymorph layer dentate gyrus. Bar is 1 mm. Representative 
MBP staining for CC and neurofibers (right). (F) Quantification of the thickness of CC in Nbn
CNS-del brain at the indicated site. 
Original magnification ×10. At least 10 mice of each genotype were analyzed, *P < 0.01 (t test). NBS and microcephaly
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The OB is formed postnatally [22]. Immature neurons 
generated from neural stem cells in the subventricu-
lar zone (SVZ) migrate towards each other in chains 
through the rostral migratory stream (RMS) to the OB 
(Supplementary information, Figure S1B). To investigate 
the defect of olfactory neurogenesis in Nbn
CNS-del mice, 
we pulse labeled mice with bromodeoxyuridine (BrdU). 
From P0 to P7, proliferating neuroprogenitors in the SVZ 
of the lateral ventricles (LV) were greatly reduced in the 
Nbn
CNS-del mice compared to that in the controls (Supple-
mentary information, Figure S1B). In addition, BrdU-
positive neurons in the RMS were also reduced in the 
Nbn
CNS-del mice compared to that in the controls (Supple-
mentary information, Figure S1B).
Nbs1 deficiency impairs ATR-Chk1 signaling in response 
to endogenous DNA damage in developing brain
Nbs1 is a key DDR molecule and DDR is critical for 
the development of the CNS [23]. We next evaluated the 
level of endogenous DNA damage in Nbn
CNS-del neocortex 
by immunohistochemical analysis on a DNA strand break 
marker, phosphorylated H2AX (γH2AX). In contrast to 
Nbn
CNS-ctr neocortex, increased γH2AX not only occurred 
in proliferating neural precursor cells at ventricular zone 
(VZ), but also aggregated in postmitotic neurons at the 
mantle zone (MZ) of Nbn-deficient brain (Figure 2A). 
This suggests that Nbs1 deficiency leads to accumula-
tion of endogenous DNA damage in line with spatial 
and temporal proliferation pattern during the cerebral 
development. Therefore, we speculated that stalled repli-
cation forks during cell proliferation and oxidative dam-
age from cellular metabolism contribute to physiological 
endogenous DNA damage, which could activate ATM/
ATR signaling through Nbs1 or MRN complex and sub-
sequently induce activation of downstream substrate p53 
to control cell proliferation and/or apoptosis (Figure 2B). 
We further explored the role of Nbs1 deficiency in 
ATM and ATR signaling during cerebral genesis in vivo. 
As proliferation of cerebral neuroprogenitors in ventricu-
lar zone start at E11-E12, we analyzed damage response 
signaling in embryonic cerebra from E12.5 to E18.5 
by western blotting. We found an efficient deletion of 
Nbs1 after E12.5, and nearly complete absence of Nbs1 
protein at E15.5 and E18.5 (Figure 2C). Notably, ATR-
mediated phosphorylation of Chk1 at serine-345 (Chk1-
S345p) in Nbn
CNS-del embryonic cortex (E15.5-E18.5) was 
largely compromised (Figure 2C). However, compatible 
with the Nbn
CNS-ctr brain, endogenous DNA damage in the 
Nbn
CNS-del brain activated ATM indicated by phosphoryla-
tion of ATM at serine-1987 (ATM-S1987p, equivalent 
to Ser1981 of human ATM), and also phosphorylated its 
downstream target Chk2 (Supplementary information, 
Figure S2).
Nbs1 deficiency impairs Chk1 localization to sites of 
DNA damage in developing neuron
To further investigate Nbs1-mediated activation of 
ATR signaling at a single cell level, we analyzed the 
phosphorylation of Chk1 (Chk1-S345p) in primary cul-
tured neural progenitors verified by nestin immunoactivi-
ty (Figure 3A). In response to hydroxylurea (HU)-induced 
replication fork blockage, Chk1-S345p was recruited 
to the sites of replication fork and formed foci in Nbs1-
proficient neurons (Figure 3A). Consistent with western 
blot analysis (Figure 2C), Nbs1-deficient neurons were 
devoid of Chk1-S345p foci in response to HU-induced 
replication fork blockage (Figure 3A). As Nbs1 and ATR 
have been shown in regulating BRCA1 protein focus 
formation responding to DNA damage [24, 25], immuno-
fluorescence staining of BRCA1 revealed that replication 
fork blockage caused by HU failed to induce BRCA1 
foci in Nbs1-deficient neurons (Figure 3B). However, 
Nbs1 deficiency did not affect the phosphorylated his-
tone H2AX (γH2AX) focus formation in HU-treated 
developing neuron (Figure 3C). The nature of Nbs1-de-
ficient primary neuron was verified by the lack of Mre11 
and Rad50 foci, and Mre11 retained in the cytoplasm in 
the absence of Nbs1 in response to replication blockage 
(Figure 3D and data not shown). These results indicate 
that in neocortex, Nbs1 deficiency mainly affects ATR-
mediated DNA damage response.
Nbs1 deficiency results in proliferation defects of neu-
ronal progenitor cells
Since ATM-Chk2 signaling remains functional in 
Nbs1-deficient neocortex (Supplementary informa-
tion, Figure S2), we next explored the consequence of 
phosphorylation of ATM and Chk2 occurring in Nbs1-
deficient developing cortex. Immunostaining and western 
blot analysis of ATM downstream target p53 revealed an 
accumulation of the p53 protein in the VZ and MZ in 
Nbs1-deficient developing cortex (Figure 4A and 4B). 
In addition, immunoactivity of p21 and its mRNA level 
were detected in the VZ and MZ of Nbs1 mutant mice 
(Figure 4A and 4C), suggesting a defective prolifera-
tion of cortical neuroprogenitors. To further confirm the 
impact of increased p53 and p21 on cell proliferation, 
we performed histological assay by in vivo labeling with 
BrdU. During neurogenesis, proliferating neuroprogeni-
tors (BrdU-positive cells) at VZ exit from cell cycle and 
migrate to the MZ, becoming postmitotic neurons (Fig-
ure 4D). Consistent with the role of Nbs1 in cerebellar 
neuroprogenitors [18] and in the lens epithelium [17], 
Nbs1 deficiency led to a significant reduction of BrdU-www.cell-research.com | Cell Research
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positive neuroprogenitors at E12.5 and E15.5 compared 
to their Nbn
CNS-ctr counterparts (Figure 4D and 4E, data 
not shown). 
Nbs1 deficiency does not affect neocortical neuronal 
apoptosis
Since p53 activation by Nbs1 deficiency leads to mas-
sive apoptosis in cerebella [18], we next evaluated the 
cell death in Nbn
CNS-del neocortex. Histological analysis 
of Nbn
CNS-del and control neocortex revealed no apparent 
pyknotic cells from E15.5 (Figure 5A) to E18.5 (data not 
shown), and negative for active caspase 3 immunoactiv-
ity. On the contrary, pyknotic cells with fragmented nu-
clei that are positive for active caspase 3 immunoactivity 
were frequently observed in Nbn
CNS-del medullar oblonga-
ta compared to that in Nbn
CNS-Ctr mice (Figure 5A, active 
caspase 3 positive cells/field at 40× original magnifica-
tion: 12.4 ± 2.3 versus 1.4 ± 1.1, n = 8, P < 0.001). 
In Nbn
CNS-del brain, although p53 was activated ubiqui-
tously (Figure 4A), the impact of Nbs1 deficiency on neu-
ronal apoptosis in different regions of the brain seems dif-
ferent. DDR-mediated p53 activation determines cellular 
outcome by regulating the expression of diverse genes 
that control cell cycle arrest and apoptosis. To explore 
the molecular mechanism of its functional diversities in 
apoptotic response, we first examined the expression lev-
els of p53 proapoptotic targets, such as Bax, Noxa and 
Puma. Although the expression levels of Bax, Noxa and 
Puma proteins were significantly increased in Nbs1-defi-
cient cerebella at P7 (as for positive control of apoptosis 
Figure 2 Nbs1 deficiency impairs ATR-Chk1 signaling in response to endogenous DNA damage in developing brain. (A) Ac-
cumulation of γH2AX exists in VZ and MZ of Nbs1-deficient embryonic brain at E12.5. Original magnification ×40. (B) Sche-
matic of the role of Nbs1 in response to DNA damage. (C) Nbs1 is required for the activation of ATR signaling during neuro-
genesis. Western blot analysis of the activation of ATR pathway in embryonic cortex. Note: In the absence of Nbs1, a marked 
reduction of Chk1-S345p at E15.5-18.5 during neurogenesis. NBS and microcephaly
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[18], Figure 5B), activation of p53 did not induce the 
expression of these proapoptotic proteins in neocortex 
of E13.5 embryos and cerebral cortex at P7 (Figure 5B). 
Notably, expression of antiapoptotic molecule Bcl-2 in 
Figure 3 Nbs1 deficiency impairs phosphorylated Chk1 focus formation. Primary cultured Nbn
CNS-ctr and Nbn
CNS-del developing 
neurons were treated with 2 mM HU for 3 h, and subjected to immunoflurescence staining with antibodies against phosphory-
lated Chk1-S345p (A), BRCA1 (B), γH2AX (C), and Nbs1 partner Mre11 (D). DAPI stains nuclei. The neuroprogenitors (A-D) 
are verified by nestin-positive immunoactivity, and at least 150 cells per staining were analyzed. www.cell-research.com | Cell Research
Rui Li et al.
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Figure 4 Nbs1 deficiency leads to defects in proliferation of neuroprogenitors during neurogenesis. (A) Activation of the p53 
pathway in Nbs1-deficient embryonic cortex. Representative immunostaining of p53 and its downstream target p21 at E12.5. 
Original magnification ×40. Insets: positive p53 and p21 cells. (B) Western blot analysis of the activation of p53 protein in 
E15.5 neocortex. (C) Nbs1 deficiency results in increased expression level of p53 target gene p21 in E15.5 neocortex and in 
P7 cerebella (as a positive control of inhibition of cell proliferation). (D) Representative in vivo BrdU labeling at E12.5. (E) His-
togram representing percentage of BrdU-positive cells at VZ of 6 high-power fields from at least five mice of each genotype 
at E12.5. *P < 0.01 (t test).NBS and microcephaly
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Figure 5 Role of Nbs1 in neuronal cell death. (A) H&E and active caspase 3 immunostaining showing cell death in medulla 
oblongata at E12.5, but not in developing cortex at E15.5. Histogram representing percentage of active caspase 3-positive 
cells at medulla oblongata of six high-power fields from at least eight mice of each genotype at E12.5 (Original magnification 
×40). *P < 0.001 (t test). (B) Nbs1 deficiency does not affect the expression of p53-dependent proapoptotic protein Bax, Noxa 
and Puma in neocortex at E13.5 and cerebral cortex at P7, but loss of Nbs1 alters cerebellar proapoptotic protein Bax, Noxa 
and Puma at P7. (C) Nbs1 deficiency results in increased expression levels of p53-mediated proapoptotic target genes Bax, 
Noxa and Puma in P7 cerebella, but has no effect on these gene expression in neocortex at E15.5 (D). At least six mice of 
each genotype were analyzed, *P < 0.05 (t test). (E) Hzf immunoactivity in Nbs1-proficient and -deficient neocortex at E15.5 
and E12.5 (inset). Original magnification ×40. Insets: positive Hzf cells in VZ region. (F) Expression level of Hzf in E15.5, 
P7 Nbs1-proficient and -deficient cortex, and P7 cerebella. (G) Expression of ASPP2, iASPP and hCAS/CSE1L proteins in 
E15.5, P7 Nbs1-proficient and -deficient cortex, and P7 cerebella. www.cell-research.com | Cell Research
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Nbs1-deficient neocortex at E13.5 and cerebral cortex at 
P7 was comparable to that in Nbs1 control mice. 
To further investigate the changes of p53-dependent 
proapoptotic proteins in Nbn
CNS-del brain were regulated at 
the transcriptional level, total RNAs from mouse neocor-
tex and cerebella were subjected to quantitative real-time 
PCR analysis. Nbs1 deficiency significantly increased 
Bax, Noxa, and Puma mRNA levels in cerebella at P7 
(Figure 5C), but had no obvious effect on these gene 
expression in neocortex at E15.5 (Figure 5D) and in ce-
rebral cortex at P7 (Supplementary information, Figure 
S3). 
Recent studies suggest that transactivation of p53-
dependent target genes can be modulated by different 
p53-interacting partners, thereby regulating cell cycle 
arrest and/or apoptosis [26]. It has been shown that he-
matopoietic zinc finger (Hzf), a zinc finger-containing 
p53 target gene, is induced by genotoxic and oxidative 
stress in a p53-dependent manner. Upon binding to p53, 
Hzf preferentially transactivates pro-arrest p53 target 
genes like p21 over its proapoptotic target genes such 
as Bax, Noxa and Puma, resulting in growth arrest and 
apoptosis inhibition [27]. Thus, the ability of p53 to re-
cruit to the promoters of cell cycle arrest target genes is 
directly regulated by Hzf. To investigate whether Hzf 
plays a role in Nbs1-deficient neuron, we first performed 
immunostaining for Hzf in Nbs1-deficient and -proficient 
neocortex at E12.5 and E15.5. Concomitant with p53 
activation, the expression of Hzf was very high in the VZ 
of Nbn
CNS-del developing cortex but was nearly absent in 
Nbn
CNS-ctr neocortex at E12.5 (Figure 5E). Although Das 
et al. has demonstrated in vitro that following prolonged 
exposure to DNA damage or extended p53 expression/
activation leads to Hzf protein degradation, which in turn 
induces activation of proapoptotic p53 targets such as 
Bax, Puma and Noxa, resulting in apoptosis, we found 
that the induction of Hzf by p53 activation existed per-
sistently in Nbn
CNS-del neocortex from E12.5 to E15.5, but 
not in medulla oblongata and primordial cerebellar neu-
rons (Figure 5E and data not shown). Western blot analy-
sis also showed that expression of Hzf was profoundly 
upregulated both in E15.5 and P7 Nbn
CNS-del cortex, but 
neuronal Nbs1 deficiency did not affect the expression 
of Hzf in cerebella at P7 (Figure 5F). This suggests that 
Hzf appears a different pattern of expression in response 
to endogenous DNA damage caused by Nbs1 deficiency 
during neurogenesis. 
In addition to Hzf, we also analyzed other p53-inter-
acting proteins in Nbs1-deficient neocortex. ASPP family 
members ASPP1 and ASPP2 interact with p53 and spe-
cifically enhance p53-induced apoptosis [28], while their 
inhibitor iASPP prevents p53 transcriptional activity 
from proapoptotic promoters by competing with ASPP1 
and ASPP2 to bind p53 [29]. The human cellular apop-
tosis susceptibility protein hCAS/CSE1L associates with 
chromatin and regulates induction of selective p53 target 
genes and apoptosis [30]. In contrast to Hzf expression in 
Nbn
CNS-del cortex and cerebella, the expression of ASPP2, 
iASPP and hCAS/CSE1L remained unchanged compared 
to that in control mice (Figure 5G). Thus, Hzf likely 
plays a key role in sustaining p53-mediated cell cycle 
arrest and defective proliferation of neuroprogenitors in 
Nbs1-deficient neocortex. 
Activation of p53 pathway is responsible for Nbs1-defi-
cient microcephaly
DNA damage in different areas of Nbn
CNS-del brain in-
duces activation of ATM target p53 protein (Figures 4A, 
4B and 6A), which controls genes expression, leading to 
developmental defects of brain [18]. To further evaluate 
the potential role of p53 in Nbs1-deficient microcephaly, 
we introduced Trp53 mutations in Nbn
CNS-del mice. His-
topathological analysis of Nbn
CNS-del;Trp53
+/+ cerebra 
revealed microcephaly and all identical cerebral defects 
seen in Nbn
CNS-del mice (data not shown). Trp53 heterozy-
gosity had a marginal effect on the loss of brain weight 
and cerebral development defects in Nbn
CNS-del mice (Fig-
ure 6B and 6C; data not shown). Notably, null mutation 
of Trp53 significantly increased brain weight (Figure 
6B), and substantially rescued the thickness of cortex (Cx) 
and CC in Nbn
CNS-del mice (Figure 6C). Moreover, null 
mutation of Trp53 largely increased granule cell num-
bers and improved the laminar structure in Nbn
CNS-del OB 
(Supplementary information, Figure S1C). 
To further understand the role of p53 on Hzf expres-
sion in Nbs1-deficient brain, we next investigated the ex-
pression level of Hzf in Nbn/Trp53 double mutant cortex 
and cerebella. Consistent with Nbs1-deficient neocortex, 
Nbn
CNS-del;Trp53
+/– cortex displayed an increased expres-
sion level of Hzf (Figure 6D), and Trp53 null mutation 
markedly reduced Hzf expression in Nbn
CNS-del cortex. In-
terestingly, Trp53 null mutation did not affect the expres-
sion of Hzf protein in Nbn
CNS-del cerebella (Figure 6D), 
implying that during neurogenesis p53-induced Hzf ex-
pression in Nbn
CNS-del brain is indeed in a region-specific 
manner. 
Discussion
In the present study, we have shown that neural inacti-
vation of Nbs1 leads to microcephaly in mice character-
ized by reduced size of cerebral cortex and thickness of 
CC, resembling neuronal abnormalities of human NBS 
patients [31]. NBS and microcephaly
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Figure 6 Introduction of Trp53 mutations in Nbs1-deficient brain largely rescues microcephaly. (A) Western blot analysis of 
p53 protein in Nbs1-deficient and -proficient brains at P7. (B) Brain weight from at least 10 mice of each genotype. *P < 0.01 
(t test). (C) Histological analysis of Trp53 mutant Nbs1-deficient cerebrum. Cx, cerebral cortex; CC, corpus callosum; DG, 
dentate gyrus; CA1/CA3, field CA1/CA3 of hippocampus. Original magnification ×4. (D) Expression level of Hzf protein in P7 
Trp53 mutant Nbs1-deficient cortex and cerebella.www.cell-research.com | Cell Research
Rui Li et al.
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Development of the cerebral cortex is a strictly regu-
lated process whereby neural progenitor cells from the 
proliferative pseudostratified ventricular zone go through 
massive expansion before they exit the cell cycle and 
form cortical neurons [32]. Neuroprogenitors are rapidly 
proliferating and potentially generate high level of oxida-
tive damage, which may lead to a high level of lesions 
encountered at the replication fork [33]. Several path-
ways may execute to recognize and repair these lesions, 
unrepaired DNA strand breaks can cause detrimental 
outcome, including chromosomal instability, cell death, 
developmental defects and neoplastic transformation 
[34]. In particular, the nervous system is susceptible to 
DNA repair deficiency, which can lead to neurodegen-
eration, microcephaly or brain tumors [33]. Our study 
using developmental brain provides direct evidence that 
endogenous DNA damage caused by SSBs/replication 
fork blockage or DSBs activates ATR-Chk1 and ATM-
Chk2-p53 pathways. Thus, it is likely that both ATM and 
ATR pathways participate in monitoring endogenous 
DNA damage during neurogenesis (see Figure 7). 
It has been shown that Nbs1 is required to modulate 
ATM or ATR activation in vitro and in vivo [3, 8, 11, 25, 
35]. Notably, we show in the present study that Nbs1 
dysfunction impairs the ATR-Chk1 signaling (see Fig-
ures 2 and 3), rather than the ATM-Chk2 pathway (see 
Supplementary information, Figure S2). It is likely that 
during neurogenesis, endogenous DNA damage caused 
by Nbs1 deficiency mainly leads to SSBs, such as rep-
lication fork blockage that activate ATR pathway. Al-
though MRN complex activate ATM kinase [3], deletion 
of Nbs1 retained accumulation of Mre11 at cytoplasmic 
compartment, presumably inactivating the MRN func-
tion [36] (see Figure 3D). However, it has been shown 
recently that in neuroprogenior cells, ATM activation 
responding to DNA damage may not require Nbs1 [37]. 
Thus, defects in ATR-Chk1 signaling in Nbs1-deficient 
neocortical neurons may convert unrepaired replication 
fork to DSBs and result in a progressive accumulation of 
persistent DSBs throughout the brain, which in turn ac-
tivate cell cycle checkpoint mediated by ATM-p53 path-
way, leading to proliferation defects and microcephaly 
[38] (see Figure 7). In supporting this hypothesis, inacti-
vation of Trp53 largely rescues microcephaly in Nbn
CNS-
del brain. 
We have shown previously that Nbs1-deficient cerebel-
lar neuroprogenitors are susceptible to DNA damage and 
postmitotic neurons with accumulation of DNA damage 
and chromosomal aberrations are cleared by massive 
cell death through activation of ATM-p53 signaling that 
leads to agenesis of cerebellum [18]. In the present study, 
although Nbs1-deficient cortical neuroprogenitors are 
susceptible to endogenous DNA damage that slows down 
proliferation (see Figure 4), distinct from cerebellar and 
medulla oblongata neurons, neocortical postmitotic neu-
rons are more tolerable to DNA damage-induced cell 
death (see Figure 5A). Thus, the cerebrum continues to 
develop into microcephaly, which is likely due to pro-
liferation defects. This functional difference of neurons 
in a specific region to endogenous DNA damage may be 
caused by a specific overactivation of Hzf upon ATM-
p53 signaling in neocortex (see Figure 5), which favors 
cell cycle arrest over apoptosis by selectively recruiting 
p53 to promoters of pro-arrest target gene such as p21, 
resulting in proliferation arrest [27]. In contrast, in Nbs1-
deficient cerebella endogenous DNA damage enhanced 
Figure 7 Working model for Nbs1 function and regulation in 
neocortex. Endogenous DNA damage during rapid development 
of neocortical neurons activates ATM-Chk2 and ATR-Chk1 
signaling. However, defective Nbs1 impairs ATR-Chk1 pathway 
rather than ATM-Chk2 signaling. ATM-Chk2 signaling in Nbs1-
deficient neocortex activates p53-Hzf pathway and induces 
defective proliferation rather than apoptosis of neuroprogenitors, 
leading to microcephaly. NBS and microcephaly
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p53-mediated cell death and proliferation arrest. There-
fore, Hzf acts both as a p53 target (Figure 6) and as an 
important regulator in p53-mediated cell fate determina-
tion during cortical neurogenesis (see Figure 7). Thus, 
this study may partly explain the respective neuropathol-
ogy in human that neurons at different regions of brain 
respond differently to endogenous DNA damage during 
neurogenesis. 
In conclusion, the present study shows a role of Nbs1 
in neocortical neurons by regulating ATR-Chk1 pathway 
in monitoring endogenous DNA damage. Neuronal Nbs1 
deletion causes defective proliferation by activation of 
p53-Hzf signaling in neocortex, but not p53-mediated 
proapototic pathway, leading to microcephaly, and neu-
rons display a region-specific response to endogenous 
DNA damage during neurogenesis. Thus, Nbs1-deficient 
mice present a useful model for further dissection of the 
molecular mechanisms of human NBS.
Materials and Methods
Mice
The generation and genotyping of Nbs1
F6/F6;nestin-Cre
+ (re-
ferred to as Nbn
CNS-del) and Trp53-deficient Nbn
CNS-del mice has been 
described previously [18]. All animal experiments were approved 
by and performed in accordance with the guidelines of the Inter-
national Agency for Research on Cancer’s Animal Care and Use 
Committee and IBMS/PUMC’s Animal Care and Use Committee.
Histopathological analysis
Animals were euthanized by carbon dioxide at the indicated 
time points. Whole mouse brains were fixed in 4% paraformal-
dehyde, followed by dehydration and paraffin embedding. His-
topathological analysis was carried out on 3-µm-thick sections 
stained with hematoxylin and eosin (H&E). Immunohistochemical 
staining was performed as described previously [39]. Antibod-
ies included those specific for: mouse anti-NeuN (Millipore, 
Chemicon, Temecula, USA), rabbit anti-γH2AX (Abcam, Cam-
bridge, UK), mouse anti-5-bromo-2′-deoxyuridine (BrdU, Sigma, 
Steinheim, Germany), rabbit anti-p53 (NovoCastra, Newcastle, 
UK), mouse anti-p21 (BD Pharmingen, San Jose, USA), and rab-
bit anti-active caspase 3 (Cell Signaling Technology, Danvers, 
USA), mouse anti-Hzf (Abnova, TaiPei, Taiwan). For the in vivo 
proliferation assay, we injected pregnant females intraperitoneally 
with 50 µg BrdU/g body weight. Embryos were collected 6 h after 
injection and fixed in 4% paraformaldehyde. 
Quantifications of BrdU and active caspase-positive cells were 
performed from at least 5 to 10 embryos of each genotype, six 
high power fields (×40) of each, and the thickness of CC was mea-
sured at a point between CA1 and CA3 using a Zeiss Axioskop 
fluorescence microscope. 
Immunoblotting
Proteins extracted from tissue and cells in RIPA buffer (20 mM 
HEPES pH 7.6, 20% glycerol, 0.5 M NaCl, 1.5 mM MgCl2, 0.2 
mM EDTA pH 8.0, 0.5% NP-40, 1 mM DTT, 1 mM PMSF, 5 µg/
ml leupeptin, 2 µg/ml aprotinin, 1mM β-glycerolphosphate, 1 mM 
Na3VO4 and 10 mM NaF) were resolved by SDS-PAGE, blot-
ted and stained with antibodies in TBST
 containing 5% non-fat 
dried milk, followed by incubation with horseradish peroxidase-
conjugated secondary antibodies and detected by the ECL reagents 
(Amersham Biosciences). The following antibodies were used: 
rabbit anti-Nbs1 (Oncogene, Swampscott, USA), mouse anti-ATM 
(Novus, Littleton, USA), mouse anti-ATM-S1987p (Rockland, 
Gilbertsville, USA), mouse anti-Chk2 (Millipore, Upstate, Te-
mecula, USA), mouse anti-PARP-1 (R&D systems, Minneapolis, 
USA), rabbit anti-ATR (Novus), rabbit anti-Chk1-S345p (Cell Sig-
naling Technology), rabbit anti-Puma (Abcam), rabbit anti-Noxa 
(Abcam), rabbit anti-Bax (Millipore, Upstate, Temecula, USA), 
rabbit anti-Bcl-2 (Millipore, Upstate, Temecula, USA), mouse 
anti-p53 (Cell Signaling Technology, Danvers, USA), rabbit anti-
Hzf (Santa Cruz Biotechnology, Santa Cruz, USA), mouse anti-
ASPP2 (Sigma, St Louis, USA), mouse anti-iASPP (Sigma), rabbit 
anti-hCAS/CSE1L (Abcam) and mouse anti-β-actin (Santa Cruz 
Biotechnology). 
Focus formation and cell imaging
Primary neurons from embryonic cortex at E13.5 were cultured 
as described previously [18]. To induce focus formation, cells were 
plated onto poly-D-lysine-coated coverslips, treated with or with-
out 2 mM HU for 3 h, and fixed. Immunofluorescence staining was 
performed as described previously [40]. Briefly, cells were washed 
once in PBS with 1 mM glycerolphosphate, 1 mM Na3VO4, 10 
mM NaF and 1 mM PMSF, and further treated with a hypotonic 
lysis solution containing 10 mM Tris-HCl pH 7.4, 2.5 mM MgCl2, 
1 mM PMSF, 1 mM glycerolphosphate, 1 mM Na3VO4, 10 mM 
NaF and 0.5% Nonidet P-40 for 8 min on ice. Subsequently cells 
were fixed in ice-cold acetone-methanol (1:1) for 30 min on ice. 
The slides were then incubated with appropriate primary antibody 
in TBST containing 5% non-fat dried milk. Slides were mounted 
in Vectashield mounting medium with DAPI (Vector Laboratories) 
and visualized under a Zeiss Axioskop fluorescence microscope 
equipped with a CCD imaging system (IP Lab Spectrum). A cell 
with at least five distinct foci in the nucleus was scored as focus 
positive, and at least 150 cells per staining were analyzed. Anti-
bodies were specific for: mouse anti-nestin (Millipore, Chemicon, 
Temecula, USA), rabbit anti-phosphorylated H2AX (γH2AX, Mil-
lipore, Upstate, Temecula, USA), rabbit anti-Mre11 (Novus), rab-
bit anti-Chk1-S345p (Cell Signaling Technology) and rabbit anti-
BRCA1 [41].
Quantitative real-time PCR
Total RNA was extracted from E15.5 mouse neocortex, P7 
cerebella and cerebral cortex in TRIzol (Invitrogen), followed by 
chloroform extraction. First-strand cDNA synthesis from total 
RNA template (2 µg) was performed with ReverTra Ace qPCR 
RT Kit (TOYOBO), oligo dT and random primers. The cDNA 
was amplified with a Bio-Rad iQ
TM5 Multicolor Real-Time PCR 
Detection System, using SYBR Green Realtime PCR Master 
Mix (TOYOBO) and PAGE-purified primers (invitrogen). Primer 
sequences were as follows: p21 (forward: 5′-ACATCTCAGGGC-
CGAAAAC-3′; reverse: 5′-CCTGACCCACAGCAGAAGA-3′), 
Puma (forward: 5′-CGTGTGGAGGAGGAGGAGT-3′; reverse: 
5′-GGGAGGAGTCCCATGAAGA-3′), Noxa (forward: 5′-TG-
GAGTGCACCGGACATAAC-3′; reverse: 5′-AGCACACTCGTC-www.cell-research.com | Cell Research
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CTTCAAGTCT-3′), Bax (forward: 5′-GCAGAGGATGATTGCT-
GACG-3′; reverse, 5′- GGGCCTTGAGCACCAGTTT-3′), and 
β-actin (forward: 5′-TGTTACCAACTGGGACGACA-3′; reverse: 
5′- GGGGTGTTGAAGGTCTCAAA-3′).
Statistical analysis
All data were presented as mean values and standard error 
of mean (SEM). Differences between groups were compared by 
analysis of variance followed by t test using Sigma plot software. 
P value < 0.05 was considered to be statistically significant.
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